You are here: Home » International » News » Others
Business Standard

CureVac CEO eyes coronavirus vaccine approval in third quarter of 2021

Haas told a news conference of foreign journalists that the company aimed to initiate rolling review of its vaccine in the first quarter of 2021

Topics
Coronavirus Vaccine | Coronavirus

Reuters  |  BERLIN 

Vaccine

BERLIN (Reuters) - German biotech company CureVac hopes to receive approval for its experimental COVID-19 vaccine in the third quarter of 2021, Chief Executive Franz-Werner Haas said on Thursday.

Haas told a news conference of foreign journalists that the company aimed to initiate rolling review of its vaccine in the first quarter of 2021.

The exact timing for final approval will depend on how many other shots are given the green light over the next few months, he added.

 

(Reporting by Caroline Copley and Ludwig Burger; Editing by Maria Sheahan)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, November 13 2020. 00:00 IST
RECOMMENDED FOR YOU
.